NovoCure Limited
Price
FilingsNewest: 8-K, Regulation FD disclosureOct 1 →InsidersNo open-market buys. 14 insiders sold $3.3M, 0 of 25 sales on a 10b5-1 plan.→PeersClosest companies: ONC, INTS, COGT→
From the filings
Figures
- Revenue
- $699.2Mlast 12 months
- Net income
- −$148.6Mlast 12 months
- Operating cash flow
- −$2.8Mlast 12 months
- Cash and equivalents
- $93.7Mat the last balance sheet
- Total debt
- $195.0Mat the last balance sheet
- Shares outstanding
- 116.4M shareson issue